In the article by Rokx et al, appearing in JAIDS: Journal of Acquired Immune Deficiency Syndromes, Vol. 68, No. 1, pp. 36-39, entitled “The Efficacy, Pharmacokinetics, and Safety of a Nevirapine to Rilpivirine Switch in Virologically Suppressed HIV-1–Infected Patients”, there is an error in the text. In the last sentence of the abstract, it reads: “substituting nevirapine for rilpivirine resulted in ongoing virological suppression…” However, as the authors switched patients from nevirapine to rilpivirine, this should read “substituting rilpivirine for nevirapine”.
Rokx C, Blonk M, Verbon A, et al.. The efficacy, pharmacokinetics, and safety of a nevirapine to rilpivirine switch in virologically suppressed HIV-1-infected patients. J Acquir Immune Defic Syndr. 2015;68:36–39.